User profiles for "author:Carlomaurizio Montecucco"
carlomaurizio montecuccoprofessor of Rheumatology, Università di Pavia Verified email at smatteo.pv.it Cited by 28131 |
Treating rheumatoid arthritis to target: recommendations of an international task force
JS Smolen, D Aletaha, JWJ Bijlsma… - Annals of the …, 2010 - ard.bmj.com
Background Aiming at therapeutic targets has reduced the risk of organ failure in many
diseases such as diabetes or hypertension. Such targets have not been defined for …
diseases such as diabetes or hypertension. Such targets have not been defined for …
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad …
F Sivera, M Andrés, L Carmona, ASR Kydd… - Annals of the …, 2014 - ard.bmj.com
We aimed to develop evidence-based multinational recommendations for the diagnosis and
management of gout. Using a formal voting process, a panel of 78 international …
management of gout. Using a formal voting process, a panel of 78 international …
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
Objectives To summarise existing evidence on a target oriented approach for rheumatoid
arthritis (RA) treatment. Methods We conducted a systematic literature search including all …
arthritis (RA) treatment. Methods We conducted a systematic literature search including all …
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
S Monti, S Balduzzi, P Delvino, E Bellis… - Annals of the …, 2020 - ard.bmj.com
Different viral agents are associated with an increased risk of more severe disease course
and respiratory complications in immunocompromised patients. 1–3 The recent outbreak of …
and respiratory complications in immunocompromised patients. 1–3 The recent outbreak of …
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse
CA Scire, C Montecucco, V Codullo, O Epis… - …, 2009 - academic.oup.com
Objectives. This study aimed to evaluate the usefulness of a systematic musculoskeletal
ultrasonographic (US) assessment in the detection of residual disease activity in patients …
ultrasonographic (US) assessment in the detection of residual disease activity in patients …
[HTML][HTML] Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven …
Background Although targeted biological treatments have transformed the outlook for
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …
Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial
R Caporali, MA Cimmino, G Ferraccioli… - Annals of Internal …, 2004 - acpjournals.org
Background: Steroids are the standard treatment for polymyalgia rheumatica. The efficacy of
the candidate drug methotrexate has not yet been demonstrated in controlled studies …
the candidate drug methotrexate has not yet been demonstrated in controlled studies …
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis
A Manzo, S Paoletti, M Carulli… - European journal of …, 2005 - Wiley Online Library
CXCL13 and CCL21 have been functionally implicated in lymphoid tissue organization both
in the upstream phases of lymphoid tissue embryogenesis and in ectopic lymphoid …
in the upstream phases of lymphoid tissue embryogenesis and in ectopic lymphoid …
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active …
GR Burmester, X Mariette, C Montecucco… - Annals of the …, 2007 - ard.bmj.com
Objective: To evaluate the safety and effectiveness of adalimumab alone or in combination
with standard disease-modifying antirheumatic drugs (DMARDs) for the treatment of …
with standard disease-modifying antirheumatic drugs (DMARDs) for the treatment of …
[HTML][HTML] Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE)
M Colaneri, L Bogliolo, P Valsecchi, P Sacchi… - Microorganisms, 2020 - mdpi.com
Objective: This study aimed to assess the role of Tocilizumab therapy (TCZ) in terms of ICU
admission and mortality rate of critically ill patients with severe COVID-19 pneumonia …
admission and mortality rate of critically ill patients with severe COVID-19 pneumonia …